| Targeting OLFM13 in colorectal cancer suppresses tumor growth and angiogenesis, and increases the efficacy of anti-PD1 based immunotherapy | Cancers |  | | 2021 | 201 | 254 |
|
| Angiogenic factor-driven inflammation promotes extravasation of human proangiogenic monocytes to tumours | Nature Communications | | | 2018 | 484 | 364 |
|
